SANCTURA XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sanctura Xr, and when can generic versions of Sanctura Xr launch?
Sanctura Xr is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in SANCTURA XR is trospium chloride. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sanctura Xr
A generic version of SANCTURA XR was approved as trospium chloride by GLENMARK GENERICS on August 13th, 2010.
Summary for SANCTURA XR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 8 |
Patent Applications: | 1,557 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SANCTURA XR |
DailyMed Link: | SANCTURA XR at DailyMed |
Recent Clinical Trials for SANCTURA XR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Neil M. Resnick | Phase 4 |
National Institute on Aging (NIA) | Phase 4 |
Karuna Therapeutics | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for SANCTURA XR
Paragraph IV (Patent) Challenges for SANCTURA XR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SANCTURA XR | Extended-release Capsules | trospium chloride | 60 mg | 022103 | 1 | 2009-03-02 |
US Patents and Regulatory Information for SANCTURA XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | SANCTURA XR | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 022103-001 | Aug 3, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SANCTURA XR
See the table below for patents covering SANCTURA XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1680110 | FORME DOSIFIEE QUOTIDIENNE DE TROSPIUM (ONCE DAILY DOSAGE FORMS OF TROSPIUM) | ⤷ Try a Trial |
European Patent Office | 2210605 | Forme dosifiée quotidienne de trospium (Once daily dosage forms of trospium) | ⤷ Try a Trial |
Australia | 2004289223 | Once daily dosage forms of trospium | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |